Revvity, Inc. (RVTY) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $156.36 (-5.63%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 14, 2026 | Luke Sergott | Barclays | $95.00 | -39.2% |
| Feb 3, 2026 | Catherine Ramsey Schulte | Robert W. Baird | $129.00 | -17.5% |
| Dec 15, 2025 | Brandon Couillard | Wells Fargo | $107.00 | -31.6% |
| Dec 15, 2025 | Luke Sergott | Barclays | $115.00 | -26.5% |
| Dec 9, 2025 | Evie Koslosky | Goldman Sachs | $105.00 | -32.8% |
| Oct 24, 2025 | Catherine Ramsey Schulte | Robert W. Baird | $122.00 | -22.0% |
| Jan 21, 2025 | Andrew Cooper | Raymond James | $140.00 | -10.5% |
| Jan 10, 2025 | Eve Burstein | Bernstein | $130.00 | -16.9% |
| Nov 4, 2024 | Paul Knight | KeyBanc | $132.00 | -15.6% |
| Oct 15, 2024 | Luke Sergott | Barclays | $140.00 | -10.5% |
| Jul 30, 2024 | Derik de Bruin | Bank of America Securities | $127.00 | -18.8% |
| Jul 29, 2024 | Tycho Peterson | Jefferies | $125.00 | -20.1% |
| Jul 29, 2024 | Daniel Arias | Stifel Nicolaus | $110.00 | -29.6% |
| Jul 29, 2024 | Patrick Donnelly | Citigroup | $135.00 | -13.7% |
| Jul 29, 2024 | Vijay Kumar | Evercore ISI | $126.00 | -19.4% |
| Apr 29, 2024 | Dan Leonard | UBS | $120.00 | -23.3% |
Top Analysts Covering RVTY
RVTY vs Sector & Market
| Metric | RVTY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.40 | 2.25 | 2.41 |
| Analyst Count | 10 | 8 | 19 |
| Target Upside | -15.5% | +153002.0% | +21.5% |
| P/E Ratio | 74.46 | 3.40 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $2.97B | $2.98B | $3.00B | 12 |
| 2027-03-28 | $728M | $737M | $744M | 6 |
| 2027-06-28 | $772M | $781M | $789M | 4 |
| 2027-09-28 | $761M | $770M | $777M | 4 |
| 2027-12-28 | $835M | $845M | $853M | 6 |
| 2028-03-28 | $753M | $762M | $769M | 6 |
| 2028-06-28 | $806M | $816M | $823M | 3 |
| 2028-09-28 | $785M | $795M | $803M | 3 |
| 2028-12-28 | $866M | $876M | $884M | 6 |
| 2029-12-28 | $3.46B | $3.48B | $3.51B | 4 |
| 2030-12-28 | $3.66B | $3.68B | $3.72B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-28 | $5.35 | $5.39 | $5.44 | 9 |
| 2027-03-28 | $1.24 | $1.26 | $1.27 | 5 |
| 2027-06-28 | $1.43 | $1.46 | $1.47 | 3 |
| 2027-09-28 | $1.45 | $1.48 | $1.50 | 3 |
| 2027-12-28 | $1.76 | $1.79 | $1.81 | 5 |
| 2028-03-28 | $1.48 | $1.50 | $1.52 | 7 |
| 2028-06-28 | $1.59 | $1.62 | $1.63 | 4 |
| 2028-09-28 | $1.55 | $1.58 | $1.60 | 4 |
| 2028-12-28 | $1.74 | $1.77 | $1.79 | 7 |
| 2029-12-28 | $7.09 | $7.16 | $7.24 | 1 |
| 2030-12-28 | $7.84 | $7.92 | $8.01 | 1 |
Frequently Asked Questions
What is the analyst consensus for RVTY?
The consensus among 10 analysts covering Revvity, Inc. (RVTY) is Buy with an average price target of $124.00.
What is the highest price target for RVTY?
The highest price target for RVTY is $140.00, set by Andrew Cooper at Raymond James on 2025-01-21.
What is the lowest price target for RVTY?
The lowest price target for RVTY is $95.00, set by Luke Sergott at Barclays on 2026-04-14.
How many analysts cover RVTY?
10 analysts have issued ratings for Revvity, Inc. in the past 12 months.
Is RVTY a buy or sell right now?
Based on 10 analyst ratings, RVTY has a consensus rating of Buy (2.40/5) with a -15.5% upside to the consensus target of $124.00.
What are the earnings estimates for RVTY?
Analysts estimate RVTY will report EPS of $5.39 for the period ending 2026-12-28, with revenue estimated at $2.98B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.